About this trial
The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified. Further, in many patients, polygenic risk is thought to give rise to pathophysiologic changes, but which specific genes affect risk are largely yet unknown. By examining genotypes in patients that present to our Cognitive Neurology and Alzheimer's Research Clinic with suspected or confirmed neurodegenerative dementia, or have a history of a familial dementia, we aim to help identify and characterize genetic mutations or polymorphisms that give rise to neurodegenerative diseases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions);
Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;
Age 18+ years old;
Consenting to a blood draw.
Disqualifiers
None
Trial population
Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions); Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;
Trial design
Cohort
Prospective
Treatments tested in this trial
Biosample collection.
Other interventionBlood draw.
Treatment groups
Trial outcomes
Primary outcomes
Blood draw for genetic status or polymorphism result.
The blood draw is taken at the time of the clinic visit. Up to 30ml will be collected by standard venipuncture.
Secondary outcomes
Demographic information.
Demographic information will be collected at the time of the clinic visit.
Medical history/Clinical diagnoses.
Will be obtained via chart review when available. This information is collected already as part of the patient's standard care.
Pathological diagnoses.
Will be obtained via chart review when available. This information is collected already as part of the patient's standard care.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.